18 May 2013
Keywords: uk, launch, boeh, ingelheim, nsaid, meloxicam, boehringer
Article | 09 September 1996
Boehringer Ingelheim has launched its non-steroidal anti-inflammatory
drug Mobic (meloxicam) in the UK, its third market after South Africa
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 September 1996
17 May 2013
© 2013 thepharmaletter.com